Sagefield Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,800
Closed -$543K 133
2023
Q2
$543K Buy
+13,800
New +$487K 0.12% 78

Sagefield Capital's ISEE Position: Q3 2023 in Review

Sagefield Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 13,800 shares — an estimated $543K sold.

Sagefield Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $543K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Sagefield Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Sagefield Capital sold 13,800 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $543K.
  • Sagefield Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Sagefield Capital's IVERIC bio, Inc. Common Stock position peaked at $543K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Sagefield Capital's 13F filing for Q3 2023, filed 14 Nov 2023.